New Haven, CT, United States of America

Sameer Sharma

This inventor holds 3 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignee: Bioxcel Therapeutics, Inc.. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sameer Sharma. Retrieved from https://idiyas.com/inventor/sameer-sharma-tiiu5ibz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Sameer Sharma - Revolutionizing Technology in New Haven

Introduction: Sameer Sharma is a visionary inventor based in New Haven, CT, known for his groundbreaking contributions to the field of technology.

Latest Patents: Sameer Sharma holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Sameer Sharma has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have had a significant impact on various industries.

Collaborations: Sameer Sharma has collaborated with top scientists, engineers, and researchers worldwide, fostering a culture of innovation and knowledge-sharing that has led to numerous successful projects and inventions.

Conclusion: Sameer Sharma's relentless passion for innovation and his commitment to pushing the boundaries of technology make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…